Cargando…

Mineralocorticoid receptor: A hidden culprit for hemodialysis vascular access dysfunction

Hemodialysis vascular access dysfunction is a common and intractable problem in clinical practice with no definitive therapy yet available. As a key mediator of vascular and cardiac maladaptive remodeling, mineralocorticoid receptor (MR) plays a pivotal role in vascular fibrosis and intimal hyperpla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Bohan, Wang, Pei, Brem, Andrew, Dworkin, Lance, Liu, Zhangsuo, Gong, Rujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354623/ https://www.ncbi.nlm.nih.gov/pubmed/30527626 http://dx.doi.org/10.1016/j.ebiom.2018.11.054

Ejemplares similares

Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3β pathway signaling
por: Lu, Minglei, et al.
Publicado: (2018)

Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats With Puromycin Aminonucleoside Nephrosis
por: Chen, Bohan, et al.
Publicado: (2022)

Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K/Akt/eNOS signaling pathway in diabetic tubulopathy
por: Yao, Lan, et al.
Publicado: (2023)

Mineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction
por: Igbekele, Aderonke E., et al.
Publicado: (2022)

The ageing kidney: Molecular mechanisms and clinical implications
por: Fang, Yudong, et al.
Publicado: (2020)

Age-related GSK3β overexpression drives podocyte senescence and glomerular aging
por: Fang, Yudong, et al.
Publicado: (2022)

Melanocortin System in Kidney Homeostasis and Disease: Novel Therapeutic Opportunities
por: Chang, Mingyang, et al.
Publicado: (2021)

Permissive effect of GSK3β on profibrogenic plasticity of renal tubular cells in progressive chronic kidney disease
por: Chen, Bohan, et al.
Publicado: (2021)

Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease
por: Shaffner, James, et al.
Publicado: (2021)

Rationale and Design of Assessing the Effectiveness of Short-Term Low-Dose Lithium Therapy in Averting Cardiac Surgery-Associated Acute Kidney Injury: A Randomized, Double Blinded, Placebo Controlled Pilot Trial
por: Sharif, Sairah, et al.
Publicado: (2021)

Uncovering a Mineralocorticoid Receptor–Dependent Adipose–Vascular Axis: Implications for Vascular Dysfunction in Obesity?
por: Jia, Guanghong, et al.
Publicado: (2016)

Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis
por: Moss, Mary E., et al.
Publicado: (2015)

GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition
por: Lu, Minglei, et al.
Publicado: (2019)

Blunt abdominal trauma: a hidden culprit
por: Chen, Wei-Liang, et al.
Publicado: (2009)

NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus
por: Ferreira, Nathanne Santos, et al.
Publicado: (2019)

Mineralocorticoid Receptor in Myeloid Cells Mediates Angiotensin II-Induced Vascular Dysfunction in Female Mice
por: Manrique-Acevedo, Camila, et al.
Publicado: (2021)

Adipose Tissue Dysfunction in Obesity: Role of Mineralocorticoid Receptor
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2022)

The Hidden Culprit: A Case of Repeated Anaphylaxis to Cremophor
por: Kim, Young Nam, et al.
Publicado: (2016)

Central Venous Disease Increases the Risk of Microbial Colonization in Hemodialysis Catheters
por: Liang, Xianhui, et al.
Publicado: (2021)

Selective deletion of endothelial mineralocorticoid receptor protects from vascular dysfunction in sodium-restricted female mice
por: Faulkner, Jessica L., et al.
Publicado: (2020)

Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension
por: Menon, Divya P., et al.
Publicado: (2021)

Hypothalamic Dysregulation; A Hidden Culprit in Multiple Sclerosis Symptoms
por: Hernandez-Cordero, Nicole Z, et al.
Publicado: (2021)

SAT674 Lipodystrophy: A Hidden Culprit In Uncontrolled Diabetes
por: Sayed, Farah El, et al.
Publicado: (2023)

Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis
por: Harvey, Adam P., et al.
Publicado: (2017)

A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification
por: Zhu, Dongxing, et al.
Publicado: (2016)

Mineralocorticoid Receptors: An Appealing Target to Treat Coronary Microvascular Dysfunction in Diabetes
por: Bender, Shawn B., et al.
Publicado: (2015)

Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction
por: Chang, Wei-Ting, et al.
Publicado: (2022)

A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction in Diabetic C57BL/6 Mice
por: Munkhjargal, Uugantsetseg, et al.
Publicado: (2023)

The Hidden Culprit in a Massive Episode of Hematemesis: A Dieulafoy's Lesion
por: Khalid, Sameen, et al.
Publicado: (2016)

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
por: Kolkhof, Peter, et al.
Publicado: (2017)

The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers
por: Tezuka, Yuta, et al.
Publicado: (2022)

Expression of genes encoding mineralocorticoid biosynthetic enzymes and the mineralocorticoid receptor, and levels of mineralocorticoids in the bovine follicle and corpus luteum
por: MUKANGWA, Memory, et al.
Publicado: (2019)

Mineralocorticoid Receptor–Mediated Vascular Insulin Resistance: An Early Contributor to Diabetes-Related Vascular Disease?
por: Bender, Shawn B., et al.
Publicado: (2013)

An experience of vascular access for hemodialysis in Brazil
por: Centofanti, Guilherme, et al.
Publicado: (2011)

Vascular access for hemodialysis: current perspectives
por: Santoro, Domenico, et al.
Publicado: (2014)

Hemodialysis Vascular Access: The Perils and Potentials
por: Banerjee, D., et al.
Publicado: (2017)

Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018)

Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling
por: Nguyen Dinh Cat, Aurelie, et al.
Publicado: (2018)

Elevated plasma leptin levels are associated with vascular access dysfunction in patients on maintenance hemodialysis
por: Yu, Teng‐Hung, et al.
Publicado: (2023)

Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity
por: Schäfer, Nicola, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rgus65sv4b579q66d4tcaggbb2